Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Japan Diabetes Care Devices Market Outlook to 2018- GlucoseMonitoring and Insulin DeliveryReport Details:Published:Septemb...
Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth....
5.3 Insulin Delivery Market, Japan, Segment Contribution (%), 2011 455.4 Insulin Delivery Overall Revenue, (2004-2018) 465...
8 Financial Deals Landscape 828.1 Partnerships 828.1.1 Insulet Expands Distribution Agreement With Ypsomed Holding 829 Rec...
2011 26Table 9: Glucose Monitoring, Japan, Revenue ($m) USD Constant, by Segment , Forecast, 2011-2018 28Table 10: Blood G...
67Table 36: Insulin Delivery, Japan, Company Share by Revenue ($m), USD Constant, 2010-201169Table 37: Diabetes Care Devic...
2011 50Figure 27: Insulin Pens, Japan, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 52Figure 28: Insulin...
Upcoming SlideShare
Loading in …5
×

Japan Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery

162 views

Published on

  • Be the first to comment

  • Be the first to like this

Japan Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery

  1. 1. Japan Diabetes Care Devices Market Outlook to 2018- GlucoseMonitoring and Insulin DeliveryReport Details:Published:September 2012No. of Pages: 92Price: Single User License – US$2500Japan Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin DeliverySummaryGlobalData’s new report, “Japan Diabetes Care Devices Market Outlook to 2018- GlucoseMonitoring and Insulin Delivery” provides key market data on the Japan Diabetes Care Devicesmarket. The report provides value (USD million), volume (units) and average price (USD) data foreach segment and sub-segment within two market categories – Glucose Monitoring and InsulinDelivery. The report also provides company shares and distribution shares data for each of theaforementioned market categories. The report is supplemented with global corporate-level profilesof the key market participants with information on company financials and pipeline products,wherever available.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by GlobalData’s team of industry experts.Scope- Market size and company share data for Diabetes Care Devices market categories – GlucoseMonitoring and Insulin Delivery.- Annualized market revenues (USD million), volume (units) and average price (USD) data foreach of the segments and sub-segments within two market categories. Data from 2004 to 2011,forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the two market categories.- Global corporate-level profiles of key companies operating within the Japan Diabetes CareDevicesmarket.- Key players covered include LifeScan, Inc., F. Hoffmann-La Roche Ltd., Novo Nordisk A/S,ARKRAY, Inc., Eli Lilly and Company, Sanofi and others.
  2. 2. Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the Japan Diabetes CareDevices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/197483-japan-diabetes-care-devices-market-outlook-to-2018-glucose-monitoring-and-insulin-delivery.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 61.2 List of Figures 72 Introduction 92.1 What is This Report About? 93 Diabetes Care Devices In Japan 103.1 Diabetes Care Devices, Market Segmentation 103.2 Diabetes Care Devices, Japan, Overall Revenue ($m) , USD Constant, 2004-2018 113.3 Diabetes Care Devices Market, Japan, Revenue Mix ($m), 2011 123.4 Diabetes Care Devices Market, Japan, Category Contribution (%), 2011 133.5 Diabetes Care Devices, Japan, Company Share (2010-2011) 204 Glucose Monitoring In Japan 224.1 Glucose Monitoring, Market Segmentation 224.2 Glucose Monitoring Market, Japan, Revenue Mix ($m), 2011 234.3 Glucose Monitoring Market, Japan, Segment Contribution (%), 2011 244.4 Glucose Monitoring Overall Revenue, (2004-2018) 254.4.1 Blood Glucose Meters, Revenue (2004-2018) 294.5 Glucose Monitoring Overall Volume (2004-2018) 334.5.1 Blood Glucose Meters, Volume (2004-2018) 374.6 Glucose Monitoring Average Price (2004-2018) 394.7 Glucose Monitoring Distribution Share (2010-2011) 404.8 Glucose Monitoring, Japan, Company Share (2010-2011) 415 Insulin Delivery In Japan 435.1 Insulin Delivery, Market Segmentation 435.2 Insulin Delivery Market, Japan, Revenue Mix ($m), 2011 44
  3. 3. 5.3 Insulin Delivery Market, Japan, Segment Contribution (%), 2011 455.4 Insulin Delivery Overall Revenue, (2004-2018) 465.4.1 Insulin Pens, Revenue (2004-2018) 505.4.2 Insulin Pumps, Revenue (2004-2018) 545.5 Insulin Delivery Overall Volume (2004-2018) 565.5.1 Insulin Pens, Volume (2004-2018) 605.5.2 Insulin Pumps, Volume (2004-2018) 645.6 Insulin Delivery Average Price (2004-2018) 665.7 Insulin Delivery Distribution Share (2010-2011) 675.8 Insulin Delivery, Japan, Company Share (2010-2011) 686 Overview of Key Companies in Japan Diabetes Care Devices Market 706.1 LifeScan, Inc. 706.1.1 Company Overview 706.1.2 Share in the Japan Diabetes Care Devices Market 706.2 F. Hoffmann-La Roche Ltd. 716.2.1 Company Overview 716.2.2 Share in the Japan Diabetes Care Devices Market 716.3 Novo Nordisk A/S 726.3.1 Company Overview 726.3.2 Share in the Japan Diabetes Care Devices Market 726.4 ARKRAY, Inc. 736.4.1 Company Overview 736.4.2 Share in the Japan Diabetes Care Devices Market 736.5 Eli Lilly and Company 746.5.1 Company Overview 746.5.2 Share in the Japan Diabetes Care Devices Market 746.6 Sanofi 756.6.1 Company Overview 756.6.2 Share in the Japan Diabetes Care Devices Market 756.7 Terumo Corporation 766.7.1 Company Overview 766.8 Abbott Laboratories 766.8.1 Company Overview 766.9 Bayer HealthCare AG 776.9.1 Company Overview 776.10 Terumo Corporation 776.10.1 Company Overview 776.11 Medtronic, Inc. 786.11.1 Company Overview 786.12 Apex Biotechnology Corp. 786.12.1 Company Overview 787 Diabetes Care Devices Market Pipeline Products 79
  4. 4. 8 Financial Deals Landscape 828.1 Partnerships 828.1.1 Insulet Expands Distribution Agreement With Ypsomed Holding 829 Recent Developments 839.1 Strategy And Business Planning 839.1.1 Aug 09, 2012: Takeda Establishes Development Center In China 839.1.2 Mar 27, 2012: Terumo Establishes New Holding Company In Singapore 839.1.3 Nov 04, 2011: Takeda Announces New Structure Of Business Operations 839.2 Research And Development 849.2.1 Apr 04, 2012: Takeda Joins Structural Genomics Consortium To Fund Collective DrugResearch 849.3 Legal and Regulatory 859.3.1 Aug 01, 2012: Terumo Files Lawsuit For Compensation Of Damages Against Olympus 859.3.2 Jun 29, 2012: Sucampo Pharma Provides Update On Anticipated Arbitration Decision 859.3.3 May 30, 2012: Sucampo Announces Change In Date Of Anticipated Arbitration Decision InDispute With Takeda 8510 Appendix 8610.1 Definitions of Markets Covered in the Report 8710.1.1 Diabetes Care Devices 8710.2 Research Methodology 8910.3 Secondary Research 8910.4 Primary Research 9010.5 Models 9010.6 Forecasts 9110.7 Expert Panels 9110.8 GlobalData Consulting 9110.9 Currency Conversion 9110.10 Contact Us 9110.11 Disclaimer 921.1 List of TablesTable 1: Diabetes Care Devices, Japan, Overall Revenue ($m) , USD Constant, 2004-2018 11Table 2: Diabetes Care Devices Market, Japan, Category Contribution (%), 2011 13Table 3: Diabetes Care Devices, Japan, Cross-Segment Analysis, 2004-2018 15Table 4: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, Historic, 2004-2011 17Table 5: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 19Table 6: Diabetes Care Devices, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011 21Table 7: Glucose Monitoring Market, Japan, Segment Contribution (%), 2011 24Table 8: Glucose Monitoring, Japan, Revenue ($m) USD Constant, by Segment , Historic, 2004-
  5. 5. 2011 26Table 9: Glucose Monitoring, Japan, Revenue ($m) USD Constant, by Segment , Forecast, 2011-2018 28Table 10: Blood Glucose Meters, Japan, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 30Table 11: Blood Glucose Meters, Japan, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 32Table 12: Glucose Monitoring, Japan, Volume (Units) by Segment, Historic, 2004-2011 34Table 13: Glucose Monitoring, Japan, Volume (Units) by Segment, Forecast, 2011-2018 36Table 14: Blood Glucose Meters, Japan, Volume (Units) by Sub-Segment, Historic, 2004-2011 37Table 15: Blood Glucose Meters, Japan, Volume (Units) by Sub-Segment, Forecast, 2011-201838Table 16: Glucose Monitoring, Japan, Average Price ($), Historic, 2004-2011 39Table 17: Glucose Monitoring, Japan, Average Price ($), Forecast, 2011-2018 39Table 18: Glucose Monitoring, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011 40Table 19: Glucose Monitoring, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011 42Table 20: Insulin Delivery Market, Japan, Segment Contribution (%), 2011 45Table 21: Insulin Delivery, Japan, Revenue ($m) USD Constant, by Segment , Historic, 2004-201147Table 22: Insulin Delivery, Japan, Revenue ($m) USD Constant, by Segment , Forecast, 2011-2018 49Table 23: Insulin Pens, Japan, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 51Table 24: Insulin Pens, Japan, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 53Table 25: Insulin Pumps (Traditional Insulin Pumps), Japan, Revenue ($m) USD Constant,Historic, 2004-2011 54Table 26: Insulin Pumps (Traditional Insulin Pumps), Japan, Revenue ($m) USD Constant,Forecast, 2011-2018 55Table 27: Insulin Delivery, Japan, Volume (Units) by Segment, Historic, 2004-2011 57Table 28: Insulin Delivery, Japan, Volume (Units) by Segment, Forecast, 2011-2018 59Table 29: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Historic, 2004-2011 61Table 30: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Forecast, 2011-2018 63Table 31: Insulin Pumps (Traditional Insulin Pumps), Japan, Volume (Units), Historic, 2004-201164Table 32: Insulin Pumps (Traditional Insulin Pumps), Japan, Volume (Units), Forecast, 2011-201865Table 33: Insulin Delivery, Japan, Average Price ($), Historic, 2004-2011 66Table 34: Insulin Delivery, Japan, Average Price ($), Forecast, 2011-2018 66Table 35: Insulin Delivery, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011
  6. 6. 67Table 36: Insulin Delivery, Japan, Company Share by Revenue ($m), USD Constant, 2010-201169Table 37: Diabetes Care Devices Market Pipeline Products 79Table 38: Insulet Expands Distribution Agreement With Ypsomed Holding 821.2 List of FiguresFigure 1: Diabetes Care Devices, Market Segmentation 10Figure 2: Diabetes Care Devices, Japan, Overall Revenue ($m) , USD Constant, 2004-2018 11Figure 3: Diabetes Care Devices Market, Japan, Revenue Mix ($m), 2011 12Figure 4: Diabetes Care Devices Market, Japan, Category Contribution (%), 2011 13Figure 5: Diabetes Care Devices, Japan, Cross-Segment Analysis, 2004-2018 14Figure 6: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, Historic, 2004-2011 16Figure 7: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 18Figure 8: Diabetes Care Devices, Japan, Company Share (%), 2011 20Figure 9: Glucose Monitoring, Market Segmentation 22Figure 10: Glucose Monitoring Market, Japan, Revenue Mix ($m), 2011 23Figure 11: Glucose Monitoring Market, Japan, Segment Contribution (%), 2011 24Figure 12: Glucose Monitoring, Japan, Revenue ($m) USD Constant, by Segment , Historic, 2004-2011 25Figure 13: Glucose Monitoring, Japan, Revenue ($m) USD Constant, by Segment , Forecast,2011-2018 27Figure 14: Blood Glucose Meters, Japan, Revenue ($m) USD Constant, by Sub-Segment,Historic, 2004-2011 29Figure 15: Blood Glucose Meters, Japan, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 31Figure 16: Glucose Monitoring, Japan, Volume (Units) by Segment, Historic, 2004-2011 33Figure 17: Glucose Monitoring, Japan, Volume (Units) by Segment, Forecast, 2011-2018 35Figure 18: Blood Glucose Meters, Japan, Volume (Units) by Sub-Segment, Historic, 2004-2011 37Figure 19: Blood Glucose Meters, Japan, Volume (Units) by Sub-Segment, Forecast, 2011-201838Figure 20: Glucose Monitoring, Japan, Company Share (%), 2011 41Figure 21: Insulin Delivery, Market Segmentation 43Figure 22: Insulin Delivery Market, Japan, Revenue Mix ($m), 2011 44Figure 23: Insulin Delivery Market, Japan, Segment Contribution (%), 2011 45Figure 24: Insulin Delivery, Japan, Revenue ($m) USD Constant, by Segment , Historic, 2004-2011 46Figure 25: Insulin Delivery, Japan, Revenue ($m) USD Constant, by Segment , Forecast, 2011-2018 48Figure 26: Insulin Pens, Japan, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
  7. 7. 2011 50Figure 27: Insulin Pens, Japan, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 52Figure 28: Insulin Pumps (Traditional Insulin Pumps), Japan, Revenue ($m) USD Constant,Historic, 2004-2011 54Figure 29: Insulin Pumps (Traditional Insulin Pumps), Japan, Revenue ($m) USD Constant,Forecast, 2011-2018 55Figure 30: Insulin Delivery, Japan, Volume (Units) by Segment, Historic, 2004-2011 56Figure 31: Insulin Delivery, Japan, Volume (Units) by Segment, Forecast, 2011-2018 58Figure 32: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Historic, 2004-2011 60Figure 33: Insulin Pens, Japan, Volume (Units) by Sub-Segment, Forecast, 2011-2018 62Figure 34: Insulin Pumps (Traditional Insulin Pumps), Japan, Volume (Units), Historic, 2004-201164Figure 35: Insulin Pumps (Traditional Insulin Pumps), Japan, Volume (Units), Forecast, 2011-201865Figure 36: Insulin Delivery, Japan, Company Share (%), 2011 68Figure 37: LifeScan, Inc., Company Share (%),Japan Diabetes Care Devices Market, 2011 70Figure 38: F. Hoffmann-La Roche Ltd., Company Share (%),Japan Diabetes Care Devices Market,2011 71Figure 39: Novo Nordisk A/S, Company Share (%),Japan Diabetes Care Devices Market, 2011 72Figure 40: ARKRAY, Inc., Company Share (%),Japan Diabetes Care Devices Market, 2011 73Figure 41: Eli Lilly and Company, Company Share (%),Japan Diabetes Care Devices Market,2011 74Figure 42: Sanof, Company Share (%),Japan Diabetes Care Devices Market, 2011 75Contact: sales@reportsandreports.com for more information.

×